Skip to main content

Series B

Executives in a conference
By Anthony Vecchione | 01:37 pm | June 18, 2025
The company will use the funds to speed up the commercialization of BiWaze Clear, scale U.S. sales initiatives, invest in clinical research and increase patient participation.